Shantanu Singh Director: Latest News, Videos and Photos of Shantanu Singh Director | Times of India Shantanu Singh Director News: Latest and Breaking News on Shantanu Singh Director. Explore Shantanu Singh Director profile at Times of India for photos, videos and latest news of Shantanu Singh Director. Also find news, photos and videos on Shantanu Singh Director Shantanu Singh Director, Shantanu Singh Director news, Shantanu Singh Director latest news, Shantanu Singh Director biography, Shantanu Singh Director photos, Shantanu Singh Director videos, Shantanu Singh Director news today

1. ShantanuSinghTaj Pharma
Latest News &Videos {Taj
Pharma}Shantanu KumarSingh's
ExecutiveDirectorTaj Pharma
Taj Pharmaceuticals Limited Shantanu Singh {Taj Pharma} Shantanu Kumar Singh's Executive Director Taj Pharma Group Shantanu
Kumar Singh, TAJ PHARMA - Company directors | Shantanu Kumar Singh is an Indian businessman, Director of Taj Pharma Group India.
He serves as a board member for the Pharma Group companies and is responsible for managing the Pharma division growth as a leading
health group aground the launched markets. Shantanu Kumar Singh is an Indian businessman. Director at Taj Pharma Group India. He
serves as a board member for the Group Indian companies and is known for consulting Mumbai entrepreneurs with innovative business
models in the financial capital. He has been recognised by heading Alzheimer disease drug trials for the UK market by venturing a new
drug discovery subsidiary, Sienna Biotec India. Further, he has been recognised to serve as a board member of several Middle East
Ministry of Health boards to improve healthcare in countries like Qatar, Tunisia and Yemen. Singh attained his education at The
Lawrence School, Sanawar, India. He further moved to England for a degree in Finance and Accounting at University of Durham, United
Kingdom. Singh holds expertise in International subsidiary planning, Implementation, Pharmaceutical APIs, Chemicals Research and
Development. Specialties: Finance and Accounting: Financial Expert with broad experience in all aspects of accounting, tax planning,
auditing and financial management. Experience in Pharmaceuticals, financial consulting and corporate venture capital. Finance Portfolio
Management and (BSE) IPO Advisory. International Corporate Communications and Mass media management. Experience | Executive
Director “ TAJ PHARMA GROUP Location: Global International Business Operations, Communication and International Conference,
Contract Manufacturing and Sales, Project Financial Forecasts and Planning, Corporate Capital Venturing, Bonds and Debenture
handling. Management Strategic Consulting including business plan & international sales strategy development. Corporate
Communication, Global Media and Press Releases, Spokesperson European Communication, Communication advisory team. Finance
department Leadership and advisory committee

2. ShantanuSinghTajPharma
LatestNews&Videos
 Shantanu Kumar Singh is an
Indian businessman, Director
ofTaj Pharma Group India. He
serves as a board member for
the Pharma Group companies
and is responsible for
managing the Pharma division
growth as a leading health
group aground the launched
markets.

3. Shantanu KumarSingh–Directorat
TajPharmaGroupandLeading
BusinessConsultant.
 Shantanu Kumar
Singh – Director
atTaj Pharma
Group and
Leading Business
Consultant.

4. ShantanuKumarSinghisanIndian
businessman,DirectorofTajPharmaGroup
India.Heservesasaboardmemberforthe
PharmaGroupcompaniesandis
responsibleformanagingthePharma
divisiongrowthasaleadinghealthgroup
agroundthelaunchedmarkets.

5. ShantanuKumarSinghisanIndian
businessman.DirectoratTajPharma
GroupIndia.Heservesasaboard
memberfortheGroupIndiancompanies
andisknownforconsultingMumbai
entrepreneurswithinnovativebusiness
modelsinthefinancialcapital.Hehas
beenrecognisedbyheadingAlzheimer’s
diseasedrugtrialsfortheUKmarketby
venturinganewdrugdiscovery
subsidiary,SiennaBiotecIndia.Further,
hehasbeenrecognisedtoserveasa
boardmemberofseveralMiddleEast
MinistryofHealthboardstoimprove
healthcareincountrieslikeQatar,Tunisia
andYemen.Singhattainedhiseducation
atTheLawrenceSchool,Sanawar,India.
HefurthermovedtoEnglandforadegree
inFinanceandAccountingatUniversityof
Durham,UnitedKingdom.Singhholds
expertiseinInternationalsubsidiary
planning,Implementation,
PharmaceuticalAPIs,ChemicalsResearch
andDevelopment.

6. Shantanu Kumar
Singh – Director atTaj
PharmaGroup
 Specialties:
Finance andAccounting: Financial Expert with broad
experience in all aspects of accounting, tax planning,
auditing and financial management. Experience in
Pharmaceuticals, financial consulting and corporate
venture capital. Finance Portfolio Management and
(BSE) IPO Advisory. InternationalCorporate
Communications and Mass media management.
 Experience
 Executive Director –TAJ PHARMA GROUP
Location: Global
 International Business Operations, Communication
and InternationalConference, Contract
Manufacturing and Sales, Project Financial
Forecasts and Planning, Corporate Capital
Venturing, Bonds and Debenture handling.
 Management StrategicConsulting including
business plan & international sales strategy
development.

7. CorporateCommunication,GlobalMediaandPressReleases,
SpokespersonEuropeanCommunication,Communicationadvisoryteam.
FinancedepartmentLeadershipandadvisorycommittee.AnnualReports
draftingteam.
SubsidiaryPlanningandImplementations,PharmaceuticalsAPIand
ChemicalsResearchanddevelopment.
Countries:EU–UK,Ireland,Poland,Germany,Austria,Romania,
Luxomburg,France
Africa–Kenya,SouthAfrica,Ghana,IvoryCoast,Senegal
Russia&CIS–Moscow,Turkmenistan
Specialties:PharmaceuticalsDistributionandMarketLaunches,Pharma
Sales,financialconsultingandcorporateventurecapital.International
CorporateCommunicationsandMassmediamanagement.Financeand
Accounting:FinancialManagementwithbroadexperienceinallaspectsof
accounting,taxplanningandauditing.
Others:ExperienceinProductMarketing,PharmaRecruitment,
RegulatorySubmissions,DossierPreparation,Qualificationsand
Validations,WHO/GMPAudits,ComplianceandRiskAssessmentandR&D
Documentation.

8. Founder&CEO–TAJ
INFOTECH INC.
Location:Global
KnowledgeisKeytotoday’s
InformationAge,thisisaNew
TypeofI.T.Firm,providesafull
rangeofinnovativeWeb
presenceproducts&servicesto
WebHosts,WebDesigners,
TechnologyConsultantsandI.T
Resellersworldwide.Most
innovativecloudtechnologyby
ourglobaldatacentersbasedin
Austin,UK,IndiaandHong
Kong.more:
http://shop.tajinfotech.com/
 Creative Director –TAJ AGRO
Location: Mumbai Area, India
 Introducing New Products,
Business Re-modeling, Business
Restructuring, Recovery and
turnaround.
 Director Sales –Taj API
Location: Mumbai Area, India
 Taj Active Pharmaceutical
Ingredients (orTajAPI) is an
international pharmaceutical
api company based in India.Taj
Api introduced Oseltamivir
Phosphate ( INN) which is drug
used for H5N1 avian influenza.
The company was first to
manufacture the raw martial for
such a cause in India.

9. Successful
executives are
often hailed as
superhuman
Executive Director
Taj Pharma,
Pharmaceuticals,
S KSinghTaj
Pharma,Shantanu
KumarSingh
 Successful executives are often hailed as superhuman, but the reality is
they’re regular people.Well, maybe not exactly!
 Given our unusual lifestyle of an entrepreneur, and that so many are fuelled by
the promise of wild riches, it comes as no surprise that we all have an inspiring
stories about overcoming adversity.
 Every business success stories is fraught with an eccentric leader, his personal
struggles, and uncommon lifestyles to find their place and translate their life
experiences into success.
 After having some success as a generics formulator, I decided launching a
dedicated oncology division to reduce the patient costs.
 So in 2013 after Completing at Durham University, England; Further pursued a
Bachelors and Masters in Indian Law, co-founded an IT firm Taj Infotech INC;
one of my most successful endeavors yet which is also fully automated
business with very little human intervention. “Prior to foundingTaj Infotech, I
completed my degrees at Durham”.
 The extra workload didn’t stop me from innovating in Pharma Sector; I was
instrumental in creating some of the first generics into the Russian andAfrican
markets.To this day, more than 35 million people all over the world have used
one of the company’s products.
 “Sometimes, the best motivation is not what someone says to you – it’s what
you’ve experienced yourself.”
Tags: Shantanu kumar Singh executive director director taj Pharmaceuticals | shantanu kumar singh executive
director taj pharma | shantanu taj pharma | Successful executives | taj pharma | taj pharmaceutical | taj
pharmaceutical director | taj pharmaceutical news | taj pharmaceutical reviews

10. Trio of Indian
pharmaceutical
s millionaires
launched 130
oncology
generics [Taj
Pharma]-
chemotherapy
drugs
 Owners ofTaj Pharmaceuticals have launched 130 innovative
oncology to increase patient access their options for
chemotherapy drugs
chemotherapy drugs, Director and CFO, dynamic entrepreneur, Pharmaceuticals, Russia’s pharma, S K Singh Taj Pharma, Shantanu KumarSingh, taj pharma industry, taj pharma news, Taj Pharmaceuticals Limited, Taj PharmaceuticalsOncology
Mr.Shantanu Singh,Abhishek Singh, Priyanka Singh directors ofTaj Pharmaceuticals Mumbai

11. Thismeansitislessbeholdentolocal
authorityfunding,whichhasplummeted
inrecentyears,pilingpressureonthe
widersector.
TajPharmaceuticalschemotherapy
divisionpaidoffa£0.9milliondebtfive
yearsagothroughthesaleandleaseback
of2OncologycarehospitalsinSaint
Petersburgtoapropertyinvestment
business,CrosswellInternational,which
wasbackedbyprivateinvestorsat
Moscow.
Labels:tajoncology,tajpharmaceutical
chemotherapydivision,tajoncology
chemotherapycompanies,
Chemotherapydrugs—Taj
Pharmaceuticals,tajchemotherapy
manufacturer,tajpharmaceutical
Chemotherapy,tajpharmaceutical
Chemotherapy,manufacturersoftaj
pharmaceuticalsoncology,Taj
pharmaceuticalschemicalsApiAgro
Products,tajpharmaceuticaloncology
india
 Indian pharmaceuticals businessmen Abhishek Singh, Taj Pharmaceuticals Limited and Priyanka Singh could be in for a major
windfall as one of Indian’s leading oncology care division manufacturing groups old unit is to be put up for sale in a deal that could
net its owners north of £2.5 million.
 This same in will lead to a further expansion of newly built Taj Oncology (chemotherapy drugs) Unit based in the Indian Territory;
Sources have not confirmed exact details of such new venture; However, the move could be looked at venturing in the regulated
markets of oncology products via an EMA, EU GMP regulated infrastructure with Oncology Section— Tablets, Capsules, Liquid and
Lyophilized Injectables all under single unit.
 Sources confirmed a Press Association report yesterday that the owners of Taj Pharmaceuticals— including Dr.Ranveer Kumar Singh
(Chairman), Mr Abhishek Singh (Director), Priyanks Singh and Shantanu Singh (Executive Director)— have mandated investment
banks and private equity holders to assess their options, the most likely of which is a sale.
 The businessmen own Taj Pharmaceuticals Oncology Unit through their private investment vehicle Singh Investments SPA, and a
formal sale process could be kicked off within weeks.
 It is thought that several buyers have already expressed an interest, but only offers higher than £2.5 million are being taken seriously.
 Dr.Ranvir Kumar Singh and Abhishek Singh (Director) and Priyanks Singh are close associates and have been involved in a number of
ventures together, including ownership of a stake in several pharmaceuticals manufacturing units which they sold in 2014.
 Trio sibling directors are best known here for their involvement in Russia and CIS markets, mainly, Armenia, Azerbaijan, Belarus,
Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russian Federation, Tajikistan, Turkmenistan, and Uzbekistan. Ms Priyanka Singh is one
of the partners behind Russia and CIS front, with more than 500 registered pharmaceutical products in state owned approx 1300–
1800 state owned pharmacies in CIS nations; which gives vast reach to the anti-cancer products and Mr Shantanu Singh for his
ownership of national distribution channel cooperation’s “stazs” such based at Saint Petersburg.
 Chemotherapy drug patients
 Taj Pharmaceuticals Oncology division currently boasts over 20 anti-cancer drug hospitals in Russia and CIS nations that house
11,000 chemotherapy patients people and employ 17,000 staff; who could be in severe drug shortage and budgetary constrains; if
such chemotherapy drugs has to be purchased from the open market at retain prices; making such chemotherapy centers to be non-
viable for poor and needy patients in India.
 Latest accounts filed with Ministry for Economic Developmentof the Russian Federation show that Taj Pharma Russia’s turnover
increased 5.3 per cent to £1.9 million in 2016, with operating profit coming in 5.6 per cent higher at £1.3 million.
 The Indian pharmaceuticals trio Mr.Abhishek Singh, Mr.Shantanu Singh and Priyanka Singh first invested in Taj Pharmaceuticals
Oncology Division in 2004, a year after the company was set up by father Dr Ranvir Singh, and are in line for a bumper payday if a
deal goes ahead and a further expansion into bigger and better infrastructure with regulatory approvals.
 Its attraction to a potential buyer for old oncology division, likely to be a private equity firm, is the fact that Taj Pharma’s primary
focus is on privately-paying residents.
Tags: chemotherapydrugs | Indian pharmaceuticalsmillionaires |
oncology generics | taj pharma | Taj Pharmaceuticals Limited | Trio of
Indian pharmaceuticals